Prognostic and immunological roles of IL18RAP in human cancers
Aging · 2023
DOI: 10.18632/aging.205017 ↗At a glance
Journal article in Aging, 2023. Written by Wu Chen and 12 co-authors. Institution: Department of Urology, Hubei International Scientific and Technological Cooperation Base of Immunotherapy, Renmin Hospital of Wuhan University, Wuhan…. Major MEDLINE topics: Neoplasms. Cited 13 times so far (Crossref); 40 references. The full text is freely available in PubMed Central.
Abstract (original language)
Across several cancers, IL18 receptor accessory protein (IL18RAP) is abnormally expressed, and this abnormality is related to tumor immunity and heterogeneous clinical outcomes. In this study, based on bioinformatics analysis, we discovered that IL18RAP is related to the human tumor microenvironment and promotes various immune cells infiltration. Additionally, the multiple immunofluorescence staining revealed that with the increased expression of IL18RAP, the number of infiltrated M1 macrophages increased. This finding was confirmed by coculture migration analysis using three human cancer cell lines (MDA-MB-231, U251, and HepG2) with IL18RAP knockdown. We discovered a positive link between IL18RAP and the majority of immunostimulators, immunoinhibitors, major histocompatibility complex (MHC) molecules, chemokines, and chemokine receptor genes using Spearman correlation analysis. Additionally, functional IL18RAP's gene set enrichment analysis (GSEA) revealed that it is related to a variety of immunological processes, such as positive regulation of interferon gamma production and positive regulation of NK cell-mediated immunity. Moreover, we used single-cell RNA sequencing analysis to detect that IL18RAP was mainly expressed in immune cells, and HALLMARK analysis confirmed that the INF-γ gene set expression was upregulated in CD8Tex cells. In addition, in human and mouse cancer cohorts, we found that the level of IL18RAP can predict the immunotherapy response. In short, our study showed that IL18RAP is a new tumor biomarker and may become a potential immunotherapeutic target in cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, Hubei International Scientific and Technological Cooperation Base of Immunotherapy, Renmin Hospital of Wuhan University, Wuhan 430000, Hubei, P.R. China.
Cite
APA
Chen, W., Song, T., Zou, F., Xia, Y., Xing, J., Yu, W., Rao, T., Zhou, X., Li, C., Ning, J., Zhao, S., Ruan, Y., & Cheng, F. (2023). Prognostic and immunological roles of IL18RAP in human cancers. Aging. https://doi.org/10.18632/aging.205017
Vancouver
Chen W, Song T, Zou F, Xia Y, Xing J, Yu W, et al. Prognostic and immunological roles of IL18RAP in human cancers. Aging. 2023. doi:10.18632/aging.205017
BibTeX
@article{Chen2023,
author = {Chen, Wu and Song, Tianbao and Zou, Fan and Xia, Yuqi and Xing, Ji and Yu, Weimin and Rao, Ting and Zhou, Xiangjun and Li, Chenglong and Ning, Jinzhuo and Zhao, Sheng and Ruan, Yuan and Cheng, Fan},
title = {Prognostic and immunological roles of IL18RAP in human cancers},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205017}
}
EUVIMED